CME Group posts strong earnings on growing trading volumes and margins. Learn the risks, market opportunities, and why it's rated a Hold.

CME Group is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key peers. See why CME stock is a Buy.

Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the second quarter of 2025. Second quarter 2025 net revenue1 was $1.3 billion, an increase of 13% over the second quarter of 2024, or ...

Q2 2025 Earnings Call Transcript July 24, 2025 Nasdaq, Inc. beats earnings expectations. Reported EPS is $0.85, expectations ...

President Donald Trump’s pressure campaign on Federal Reserve Chair Jerome Powell will intensify on Thursday, with ...

The altcoin season index surged to 58, indicating a potential rally for altcoins. JasmyCoin, Polkadot, and Dogwifhat are ...

House deals a blow to “Crypto Week,” ASML warns on 2026 growth, a promising Chinese weight-loss drug, and more news to start your day.

Though recently expanding into Solana and XRP futures the derivatives exchange giant is drawing the line at meme coins, ...

Dennis Suskind, Board Member at CME Group CME, reported an insider buy on June 26, according to a new SEC filing. What Happened: In a significant move reported in a Form 4 filing with the U.S ...

CME Group: Delving into Financials Revenue Growth: CME Group displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 10.38%.